City Holding Co’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.31K Buy
+28
New +$5.27K ﹤0.01% 534
2025
Q4
Sell
-77
Closed -$11.7K 585
2025
Q3
$11.7K Buy
+77
New +$11.7K ﹤0.01% 478
2018
Q4
Sell
-87
Closed -$7K 493
2018
Q3
$7K Hold
87
﹤0.01% 409
2018
Q2
$6K Sell
87
-75
-46% -$5.4K ﹤0.01% 422
2018
Q1
$11K Hold
162
﹤0.01% 388
2017
Q4
$11K Hold
162
﹤0.01% 389
2017
Q3
$11K Hold
162
﹤0.01% 385
2017
Q2
$11K Buy
162
+75
+86% +$4.9K ﹤0.01% 387
2017
Q1
$5K Hold
87
﹤0.01% 459
2016
Q4
$5K Hold
87
﹤0.01% 436
2016
Q3
$6K Hold
87
﹤0.01% 408
2016
Q2
$5K Buy
+87
New +$5.05K ﹤0.01% 437

Other funds holding AZN

City Holding Co's AZN Position: Q2 2026 in Review

City Holding Co opened a new position in AstraZeneca (AZN) in Q2 2026: 28 shares worth $5.31K. The stake represents ﹤0.01% of the portfolio and ranks #534 among its holdings. This is a return to the name: City Holding Co previously reported a position in AZN as recently as Q3 2025.

City Holding Co first reported a position in AZN in Q2 2016 and has held it in 12 quarters since. The position peaked at $11.7K in Q3 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • City Holding Co held 28 shares of AstraZeneca worth $5.31K as of Q2 2026.
  • AstraZeneca was a new City Holding Co position in Q2 2026.
  • AstraZeneca made up ﹤0.01% of City Holding Co's portfolio in Q2 2026, its #534 holding.
  • City Holding Co first reported a position in AstraZeneca in Q2 2016 and has held it in 12 quarters since.
  • City Holding Co's AstraZeneca position peaked at $11.7K in Q3 2025.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on City Holding Co's 13F filing for Q2 2026, filed 10 Jul 2026.